# Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema

> **NCT02471651** · PHASE4 · COMPLETED · sponsor: **California Retina Consultants** · enrollment: 40 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Dexamethasone intravitreal implant (0.7 mg)
- **DRUG:** Intravitreal anti-VEGF injection

## Key facts

- **NCT ID:** NCT02471651
- **Lead sponsor:** California Retina Consultants
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2018-10-24
- **Final completion:** 2018-10-24
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471651, "Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02471651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*